NCIt related terms : SATOREOTIDE TETRAXETAN LUTETIUM-177;
NCIt definition : A radioconjugate consisting of the somatostatin antagonistic peptide satoreotide tetraxetan
(JR11) that is linked, via the chelating agent dodecanetetraacetic acid (DOTA), to
the beta-emitting radioisotope lutetium Lu 177, with potential antineoplastic activity
and imaging activity during positron emission tomography/computed tomography (PET/CT).
Upon administration, lutetium Lu 177-DOTA-JR11 binds to somatostatin receptors (SSTRs),
with high affinity for SSTR2, present on the cell membranes of many types of neuroendocrine
tumor (NET) cells. Upon binding and internalization, this radioconjugate specifically
delivers a cytotoxic dose of beta radiation to SSTR-positive cells. SSTRs have been
shown to be present in large numbers on NETs and their metastases, while most normal
tissues express low levels of SSTRs.;
UNII : CAX3X53UL6;
InChIKey : LGPOVIJRCHASEQ-TWMOUGLCSA-K;
CAS number : 1934243-21-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1934243-21-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;